Modelling T-cell immunity against hepatitis C virus with liver organoids in a microfluidic coculture system

Hepatitis C virus (HCV) remains a global public health challenge with an estimated 71 million people chronically infected, with surges in new cases and no effective vaccine. New methods are needed to study the human immune response to HCV since in vivo animal models are limited and in vitro cancer c...

Descripción completa

Detalles Bibliográficos
Autores principales: Natarajan, Vaishaali, Simoneau, Camille R., Erickson, Ann L., Meyers, Nathan L., Baron, Jody L., Cooper, Stewart, McDevitt, Todd C., Ott, Melanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889170/
https://www.ncbi.nlm.nih.gov/pubmed/35232252
http://dx.doi.org/10.1098/rsob.210320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889170/
https://www.ncbi.nlm.nih.gov/pubmed/35232252
http://dx.doi.org/10.1098/rsob.210320

Ejemplares similares